Cargando…

SARS-CoV-2 vaccination efficacy on hospitalisation and variants

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Rozencwajg, Sacha, Blet, Alice, Lamer, Antoine, Boisson, Matthieu, Clavier, Thomas, Abou-Arab, Osama
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062906/ https://www.ncbi.nlm.nih.gov/pubmed/33901708 http://dx.doi.org/10.1016/j.accpm.2021.100867

Ejemplares similares

SARS-CoV-2 vaccination efficacy on hospitalisation and variants
por: Rozencwajg, Sacha, et al.
Publicado: (2021)

Efficacité vaccinale sur les hospitalisations liées au COVID-19 et les variants()
por: Rozencwajg, Sacha, et al.
Publicado: (2021)

Hospitalisation associated with SARS-CoV-2 delta variant in Denmark
por: Bager, Peter, et al.
Publicado: (2021)

Impact of vaccination on the symptoms of hospitalised patients with SARS-CoV-2 Delta variant (B.1.617.1) infection
por: Epaulard, Olivier, et al.
Publicado: (2022)

Outcomes and survival prediction models for severe adult acute respiratory distress syndrome treated with extracorporeal membrane oxygenation
por: Rozencwajg, Sacha, et al.
Publicado: (2016)

Transforming Anesthesia Data Into the Observational Medical Outcomes Partnership Common Data Model: Development and Usability Study
por: Lamer, Antoine, et al.
Publicado: (2021)

Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies
por: Bian, Lianlian, et al.
Publicado: (2021)

Pure SARS-CoV-2 related AVDS (Acute Vascular Distress Syndrome)
por: Jounieaux, Vincent, et al.
Publicado: (2021)

SARS-CoV-2 Variants and Vaccines
por: Krause, Philip R., et al.
Publicado: (2021)

Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy
por: Rayati Damavandi, Amirmasoud, et al.
Publicado: (2022)

Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies
por: Sharun, Khan, et al.
Publicado: (2021)

Research progress on vaccine efficacy against SARS-CoV-2 variants of concern
por: Bian, Lianlian, et al.
Publicado: (2022)

COVID-19 vaccines: A race against time
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

Vaccins COVID-19 : une course contre la montre
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study
por: Bager, Peter, et al.
Publicado: (2022)

SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines
por: Khan, Abbas, et al.
Publicado: (2021)

The emergence of SARS-CoV-2 variants threatens to decrease the efficacy of neutralizing antibodies and vaccines
por: Murano, Kensaku, et al.
Publicado: (2021)

A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants
por: Rabaan, Ali A., et al.
Publicado: (2022)

SARS-CoV-2 infection in ambulatory and hospitalised Spanish children
por: de Ceano-Vivas, María, et al.
Publicado: (2020)

COVID-19 vaccine boosters: What do we know so far?
por: Kherabi, Yousra, et al.
Publicado: (2021)

Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
por: Hu, Ye-Fan, et al.
Publicado: (2022)

Efficacy and safety of SARS-CoV-2 vaccination in liver transplant recipients
por: Meunier, Lucy, et al.
Publicado: (2022)

Global emergence of SARS-CoV-2 variants: new foresight needed for improved vaccine efficacy
por: Yadav, Pragya D, et al.
Publicado: (2022)

Omicron, a new SARS-CoV-2 variant: assessing the impact on severity and vaccines efficacy
por: Joshi, Gaurav, et al.
Publicado: (2022)

Dose de rappel du vaccin COVID-19 : que savons-nous à ce jour ?
por: Kherabi, Yousra, et al.
Publicado: (2022)

Caractéristiques des patients hospitalisés avec un variant delta du SARS-CoV-2 (B.1.617.2) selon leur statut vaccinal
por: Epaulard, O., et al.
Publicado: (2022)

Effectiveness of antithrombotic prophylaxis in hospitalised patients with SARS-CoV-2 infection
por: Quiros Ambel, Helena, et al.
Publicado: (2023)

Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection
por: Sun, Fangfang, et al.
Publicado: (2022)

Prediction of hospitalisations based on wastewater-based SARS-CoV-2 epidemiology
por: Schenk, Hannes, et al.
Publicado: (2023)

Emerging vaccine-breakthrough SARS-CoV-2 variants
por: Wang, Rui, et al.
Publicado: (2021)

SARS-CoV-2 Variants, Vaccines, and Host Immunity
por: Mistry, Priyal, et al.
Publicado: (2022)

Vaccine Breakthrough Infections with SARS-CoV-2 Variants
por: Hacisuleyman, Ezgi, et al.
Publicado: (2021)

Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia
por: Vercueil, Colin, et al.
Publicado: (2021)

Monitoring of Both Humoral and Cellular Immunities Could Early Predict COVID-19 Vaccine Efficacy Against the Different SARS-CoV2 Variants
por: Vogrig, Manon, et al.
Publicado: (2022)

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
por: Zhang, Xi-Ru, et al.
Publicado: (2023)

Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants
por: Deming, Damon, et al.
Publicado: (2006)

Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
por: Ramesh, Sindhu, et al.
Publicado: (2021)

Impact of B.1.617 and RBD SARS-CoV-2 variants on vaccine efficacy: An in-silico approach
por: Ranjan, Prashant, et al.
Publicado: (2022)

More data needed on efficacy and safety of monovalent vaccines against SARS-CoV-2 omicron variants
por: Monach, Paul A, et al.
Publicado: (2023)

Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021
por: Martínez-Baz, Iván, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ttlv0qoj204u8i8s4urbio33jj